眼用抗ウイルス薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Ophthalmic Antivirals Market Insights, Forecast to 2028

• レポートコード：QY2207E10432 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の眼用抗ウイルス薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼用抗ウイルス薬の世界市場のxxx％を占める「溶液」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の眼用抗ウイルス薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの眼用抗ウイルス薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの眼用抗ウイルス薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 眼用抗ウイルス薬のグローバル主要メーカーには、Novartis、Allergan、Valeant Pharmaceuticals、Santen Pharmaceutical、Lupin Pharmaceuticals、Apotex、Akorn、Fera Pharmaceuticals、Shenyang Xingqi Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 眼用抗ウイルス薬市場は、種類と用途によって区分されます。世界の眼用抗ウイルス薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 溶液、懸濁液、ゲル/軟膏 【用途別セグメント】 病院、薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 眼用抗ウイルス薬製品概要 - 種類別市場（溶液、懸濁液、ゲル/軟膏） - 用途別市場（病院、薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の眼用抗ウイルス薬販売量予測2017-2028 - 世界の眼用抗ウイルス薬売上予測2017-2028 - 眼用抗ウイルス薬の地域別販売量 - 眼用抗ウイルス薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別眼用抗ウイルス薬販売量 - 主要メーカー別眼用抗ウイルス薬売上 - 主要メーカー別眼用抗ウイルス薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（溶液、懸濁液、ゲル/軟膏） - 眼用抗ウイルス薬の種類別販売量 - 眼用抗ウイルス薬の種類別売上 - 眼用抗ウイルス薬の種類別価格 ・用途別市場規模（病院、薬局、その他） - 眼用抗ウイルス薬の用途別販売量 - 眼用抗ウイルス薬の用途別売上 - 眼用抗ウイルス薬の用途別価格 ・北米市場 - 北米の眼用抗ウイルス薬市場規模（種類別、用途別） - 主要国別の眼用抗ウイルス薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの眼用抗ウイルス薬市場規模（種類別、用途別） - 主要国別の眼用抗ウイルス薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の眼用抗ウイルス薬市場規模（種類別、用途別） - 主要国別の眼用抗ウイルス薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の眼用抗ウイルス薬市場規模（種類別、用途別） - 主要国別の眼用抗ウイルス薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの眼用抗ウイルス薬市場規模（種類別、用途別） - 主要国別の眼用抗ウイルス薬市場規模（トルコ、サウジアラビア） ・企業情報 Novartis、Allergan、Valeant Pharmaceuticals、Santen Pharmaceutical、Lupin Pharmaceuticals、Apotex、Akorn、Fera Pharmaceuticals、Shenyang Xingqi Pharma ・産業チェーン及び販売チャネル分析 - 眼用抗ウイルス薬の産業チェーン分析 - 眼用抗ウイルス薬の原材料 - 眼用抗ウイルス薬の生産プロセス - 眼用抗ウイルス薬の販売及びマーケティング - 眼用抗ウイルス薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 眼用抗ウイルス薬の産業動向 - 眼用抗ウイルス薬のマーケットドライバー - 眼用抗ウイルス薬の課題 - 眼用抗ウイルス薬の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Ophthalmic Antivirals Market
Due to the COVID-19 pandemic, the global Ophthalmic Antivirals market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Solutions accounting for % of the Ophthalmic Antivirals global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Ophthalmic Antivirals market size is valued at US$ million in 2021, while the US and Europe Ophthalmic Antivirals are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ophthalmic Antivirals landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Ophthalmic Antivirals include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Fera Pharmaceuticals and Shenyang Xingqi Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ophthalmic Antivirals Scope and Segment
Ophthalmic Antivirals market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ophthalmic Antivirals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Solutions
Suspensions
Gels or Ointments
Segment by Application
Hospital
Pharmacy
Others
By Company
Novartis
Allergan
Valeant Pharmaceuticals
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Fera Pharmaceuticals
Shenyang Xingqi Pharma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Ophthalmic Antivirals Product Introduction
1.2 Market by Type
1.2.1 Global Ophthalmic Antivirals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Solutions
1.2.3 Suspensions
1.2.4 Gels or Ointments
1.3 Market by Application
1.3.1 Global Ophthalmic Antivirals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ophthalmic Antivirals Sales Estimates and Forecasts 2017-2028
2.2 Global Ophthalmic Antivirals Revenue Estimates and Forecasts 2017-2028
2.3 Global Ophthalmic Antivirals Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ophthalmic Antivirals Sales by Region
2.4.1 Global Ophthalmic Antivirals Sales by Region (2017-2022)
2.4.2 Global Sales Ophthalmic Antivirals by Region (2023-2028)
2.5 Global Ophthalmic Antivirals Revenue by Region
2.5.1 Global Ophthalmic Antivirals Revenue by Region (2017-2022)
2.5.2 Global Ophthalmic Antivirals Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ophthalmic Antivirals Sales by Manufacturers
3.1.1 Global Top Ophthalmic Antivirals Manufacturers by Sales (2017-2022)
3.1.2 Global Ophthalmic Antivirals Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ophthalmic Antivirals in 2021
3.2 Global Ophthalmic Antivirals Revenue by Manufacturers
3.2.1 Global Ophthalmic Antivirals Revenue by Manufacturers (2017-2022)
3.2.2 Global Ophthalmic Antivirals Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ophthalmic Antivirals Revenue in 2021
3.3 Global Ophthalmic Antivirals Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ophthalmic Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ophthalmic Antivirals Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ophthalmic Antivirals Sales by Type
4.1.1 Global Ophthalmic Antivirals Historical Sales by Type (2017-2022)
4.1.2 Global Ophthalmic Antivirals Forecasted Sales by Type (2023-2028)
4.1.3 Global Ophthalmic Antivirals Sales Market Share by Type (2017-2028)
4.2 Global Ophthalmic Antivirals Revenue by Type
4.2.1 Global Ophthalmic Antivirals Historical Revenue by Type (2017-2022)
4.2.2 Global Ophthalmic Antivirals Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ophthalmic Antivirals Revenue Market Share by Type (2017-2028)
4.3 Global Ophthalmic Antivirals Price by Type
4.3.1 Global Ophthalmic Antivirals Price by Type (2017-2022)
4.3.2 Global Ophthalmic Antivirals Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ophthalmic Antivirals Sales by Application
5.1.1 Global Ophthalmic Antivirals Historical Sales by Application (2017-2022)
5.1.2 Global Ophthalmic Antivirals Forecasted Sales by Application (2023-2028)
5.1.3 Global Ophthalmic Antivirals Sales Market Share by Application (2017-2028)
5.2 Global Ophthalmic Antivirals Revenue by Application
5.2.1 Global Ophthalmic Antivirals Historical Revenue by Application (2017-2022)
5.2.2 Global Ophthalmic Antivirals Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ophthalmic Antivirals Revenue Market Share by Application (2017-2028)
5.3 Global Ophthalmic Antivirals Price by Application
5.3.1 Global Ophthalmic Antivirals Price by Application (2017-2022)
5.3.2 Global Ophthalmic Antivirals Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ophthalmic Antivirals Market Size by Type
6.1.1 North America Ophthalmic Antivirals Sales by Type (2017-2028)
6.1.2 North America Ophthalmic Antivirals Revenue by Type (2017-2028)
6.2 North America Ophthalmic Antivirals Market Size by Application
6.2.1 North America Ophthalmic Antivirals Sales by Application (2017-2028)
6.2.2 North America Ophthalmic Antivirals Revenue by Application (2017-2028)
6.3 North America Ophthalmic Antivirals Market Size by Country
6.3.1 North America Ophthalmic Antivirals Sales by Country (2017-2028)
6.3.2 North America Ophthalmic Antivirals Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ophthalmic Antivirals Market Size by Type
7.1.1 Europe Ophthalmic Antivirals Sales by Type (2017-2028)
7.1.2 Europe Ophthalmic Antivirals Revenue by Type (2017-2028)
7.2 Europe Ophthalmic Antivirals Market Size by Application
7.2.1 Europe Ophthalmic Antivirals Sales by Application (2017-2028)
7.2.2 Europe Ophthalmic Antivirals Revenue by Application (2017-2028)
7.3 Europe Ophthalmic Antivirals Market Size by Country
7.3.1 Europe Ophthalmic Antivirals Sales by Country (2017-2028)
7.3.2 Europe Ophthalmic Antivirals Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ophthalmic Antivirals Market Size by Type
8.1.1 Asia Pacific Ophthalmic Antivirals Sales by Type (2017-2028)
8.1.2 Asia Pacific Ophthalmic Antivirals Revenue by Type (2017-2028)
8.2 Asia Pacific Ophthalmic Antivirals Market Size by Application
8.2.1 Asia Pacific Ophthalmic Antivirals Sales by Application (2017-2028)
8.2.2 Asia Pacific Ophthalmic Antivirals Revenue by Application (2017-2028)
8.3 Asia Pacific Ophthalmic Antivirals Market Size by Region
8.3.1 Asia Pacific Ophthalmic Antivirals Sales by Region (2017-2028)
8.3.2 Asia Pacific Ophthalmic Antivirals Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ophthalmic Antivirals Market Size by Type
9.1.1 Latin America Ophthalmic Antivirals Sales by Type (2017-2028)
9.1.2 Latin America Ophthalmic Antivirals Revenue by Type (2017-2028)
9.2 Latin America Ophthalmic Antivirals Market Size by Application
9.2.1 Latin America Ophthalmic Antivirals Sales by Application (2017-2028)
9.2.2 Latin America Ophthalmic Antivirals Revenue by Application (2017-2028)
9.3 Latin America Ophthalmic Antivirals Market Size by Country
9.3.1 Latin America Ophthalmic Antivirals Sales by Country (2017-2028)
9.3.2 Latin America Ophthalmic Antivirals Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ophthalmic Antivirals Market Size by Type
10.1.1 Middle East and Africa Ophthalmic Antivirals Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ophthalmic Antivirals Revenue by Type (2017-2028)
10.2 Middle East and Africa Ophthalmic Antivirals Market Size by Application
10.2.1 Middle East and Africa Ophthalmic Antivirals Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ophthalmic Antivirals Revenue by Application (2017-2028)
10.3 Middle East and Africa Ophthalmic Antivirals Market Size by Country
10.3.1 Middle East and Africa Ophthalmic Antivirals Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ophthalmic Antivirals Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Ophthalmic Antivirals Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Ophthalmic Antivirals Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Valeant Pharmaceuticals
11.3.1 Valeant Pharmaceuticals Corporation Information
11.3.2 Valeant Pharmaceuticals Overview
11.3.3 Valeant Pharmaceuticals Ophthalmic Antivirals Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Valeant Pharmaceuticals Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Valeant Pharmaceuticals Recent Developments
11.4 Santen Pharmaceutical
11.4.1 Santen Pharmaceutical Corporation Information
11.4.2 Santen Pharmaceutical Overview
11.4.3 Santen Pharmaceutical Ophthalmic Antivirals Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Santen Pharmaceutical Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Santen Pharmaceutical Recent Developments
11.5 Lupin Pharmaceuticals
11.5.1 Lupin Pharmaceuticals Corporation Information
11.5.2 Lupin Pharmaceuticals Overview
11.5.3 Lupin Pharmaceuticals Ophthalmic Antivirals Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Lupin Pharmaceuticals Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lupin Pharmaceuticals Recent Developments
11.6 Apotex
11.6.1 Apotex Corporation Information
11.6.2 Apotex Overview
11.6.3 Apotex Ophthalmic Antivirals Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Apotex Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Apotex Recent Developments
11.7 Akorn
11.7.1 Akorn Corporation Information
11.7.2 Akorn Overview
11.7.3 Akorn Ophthalmic Antivirals Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Akorn Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Akorn Recent Developments
11.8 Fera Pharmaceuticals
11.8.1 Fera Pharmaceuticals Corporation Information
11.8.2 Fera Pharmaceuticals Overview
11.8.3 Fera Pharmaceuticals Ophthalmic Antivirals Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Fera Pharmaceuticals Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fera Pharmaceuticals Recent Developments
11.9 Shenyang Xingqi Pharma
11.9.1 Shenyang Xingqi Pharma Corporation Information
11.9.2 Shenyang Xingqi Pharma Overview
11.9.3 Shenyang Xingqi Pharma Ophthalmic Antivirals Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Shenyang Xingqi Pharma Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shenyang Xingqi Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ophthalmic Antivirals Industry Chain Analysis
12.2 Ophthalmic Antivirals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ophthalmic Antivirals Production Mode & Process
12.4 Ophthalmic Antivirals Sales and Marketing
12.4.1 Ophthalmic Antivirals Sales Channels
12.4.2 Ophthalmic Antivirals Distributors
12.5 Ophthalmic Antivirals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ophthalmic Antivirals Industry Trends
13.2 Ophthalmic Antivirals Market Drivers
13.3 Ophthalmic Antivirals Market Challenges
13.4 Ophthalmic Antivirals Market Restraints
14 Key Findings in The Global Ophthalmic Antivirals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Ophthalmic Antivirals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Solutions
Table 3. Major Manufacturers of Suspensions
Table 4. Major Manufacturers of Gels or Ointments
Table 5. Global Ophthalmic Antivirals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Ophthalmic Antivirals Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Ophthalmic Antivirals Sales by Region (2017-2022) & (K Units)
Table 8. Global Ophthalmic Antivirals Sales Market Share by Region (2017-2022)
Table 9. Global Ophthalmic Antivirals Sales by Region (2023-2028) & (K Units)
Table 10. Global Ophthalmic Antivirals Sales Market Share by Region (2023-2028)
Table 11. Global Ophthalmic Antivirals Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Ophthalmic Antivirals Revenue Market Share by Region (2017-2022)
Table 13. Global Ophthalmic Antivirals Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Ophthalmic Antivirals Revenue Market Share by Region (2023-2028)
Table 15. Global Ophthalmic Antivirals Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Ophthalmic Antivirals Sales Share by Manufacturers (2017-2022)
Table 17. Global Ophthalmic Antivirals Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Ophthalmic Antivirals Revenue Share by Manufacturers (2017-2022)
Table 19. Ophthalmic Antivirals Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Ophthalmic Antivirals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Ophthalmic Antivirals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Antivirals as of 2021)
Table 22. Ophthalmic Antivirals Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Ophthalmic Antivirals Product Offered
Table 24. Date of Manufacturers Enter into Ophthalmic Antivirals Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ophthalmic Antivirals Sales by Type (2017-2022) & (K Units)
Table 27. Global Ophthalmic Antivirals Sales by Type (2023-2028) & (K Units)
Table 28. Global Ophthalmic Antivirals Sales Share by Type (2017-2022)
Table 29. Global Ophthalmic Antivirals Sales Share by Type (2023-2028)
Table 30. Global Ophthalmic Antivirals Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Ophthalmic Antivirals Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Ophthalmic Antivirals Revenue Share by Type (2017-2022)
Table 33. Global Ophthalmic Antivirals Revenue Share by Type (2023-2028)
Table 34. Ophthalmic Antivirals Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Ophthalmic Antivirals Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Ophthalmic Antivirals Sales by Application (2017-2022) & (K Units)
Table 37. Global Ophthalmic Antivirals Sales by Application (2023-2028) & (K Units)
Table 38. Global Ophthalmic Antivirals Sales Share by Application (2017-2022)
Table 39. Global Ophthalmic Antivirals Sales Share by Application (2023-2028)
Table 40. Global Ophthalmic Antivirals Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Ophthalmic Antivirals Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Ophthalmic Antivirals Revenue Share by Application (2017-2022)
Table 43. Global Ophthalmic Antivirals Revenue Share by Application (2023-2028)
Table 44. Ophthalmic Antivirals Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Ophthalmic Antivirals Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Ophthalmic Antivirals Sales by Type (2017-2022) & (K Units)
Table 47. North America Ophthalmic Antivirals Sales by Type (2023-2028) & (K Units)
Table 48. North America Ophthalmic Antivirals Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Ophthalmic Antivirals Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Ophthalmic Antivirals Sales by Application (2017-2022) & (K Units)
Table 51. North America Ophthalmic Antivirals Sales by Application (2023-2028) & (K Units)
Table 52. North America Ophthalmic Antivirals Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Ophthalmic Antivirals Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Ophthalmic Antivirals Sales by Country (2017-2022) & (K Units)
Table 55. North America Ophthalmic Antivirals Sales by Country (2023-2028) & (K Units)
Table 56. North America Ophthalmic Antivirals Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Ophthalmic Antivirals Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Ophthalmic Antivirals Sales by Type (2017-2022) & (K Units)
Table 59. Europe Ophthalmic Antivirals Sales by Type (2023-2028) & (K Units)
Table 60. Europe Ophthalmic Antivirals Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Ophthalmic Antivirals Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Ophthalmic Antivirals Sales by Application (2017-2022) & (K Units)
Table 63. Europe Ophthalmic Antivirals Sales by Application (2023-2028) & (K Units)
Table 64. Europe Ophthalmic Antivirals Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Ophthalmic Antivirals Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Ophthalmic Antivirals Sales by Country (2017-2022) & (K Units)
Table 67. Europe Ophthalmic Antivirals Sales by Country (2023-2028) & (K Units)
Table 68. Europe Ophthalmic Antivirals Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Ophthalmic Antivirals Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Ophthalmic Antivirals Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Ophthalmic Antivirals Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Ophthalmic Antivirals Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Ophthalmic Antivirals Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Ophthalmic Antivirals Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Ophthalmic Antivirals Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Ophthalmic Antivirals Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Ophthalmic Antivirals Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Ophthalmic Antivirals Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Ophthalmic Antivirals Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Ophthalmic Antivirals Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Ophthalmic Antivirals Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Ophthalmic Antivirals Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Ophthalmic Antivirals Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Ophthalmic Antivirals Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Ophthalmic Antivirals Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Ophthalmic Antivirals Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Ophthalmic Antivirals Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Ophthalmic Antivirals Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Ophthalmic Antivirals Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Ophthalmic Antivirals Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Ophthalmic Antivirals Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Ophthalmic Antivirals Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Ophthalmic Antivirals Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Ophthalmic Antivirals Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Ophthalmic Antivirals Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Ophthalmic Antivirals Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Ophthalmic Antivirals Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Ophthalmic Antivirals Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Ophthalmic Antivirals Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Ophthalmic Antivirals Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Ophthalmic Antivirals Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Ophthalmic Antivirals Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Ophthalmic Antivirals Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Ophthalmic Antivirals Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Ophthalmic Antivirals Revenue by Country (2023-2028) & (US$ Million)
Table 106. Novartis Corporation Information
Table 107. Novartis Description and Major Businesses
Table 108. Novartis Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Novartis Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Novartis Recent Developments
Table 111. Allergan Corporation Information
Table 112. Allergan Description and Major Businesses
Table 113. Allergan Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Allergan Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Allergan Recent Developments
Table 116. Valeant Pharmaceuticals Corporation Information
Table 117. Valeant Pharmaceuticals Description and Major Businesses
Table 118. Valeant Pharmaceuticals Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Valeant Pharmaceuticals Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Valeant Pharmaceuticals Recent Developments
Table 121. Santen Pharmaceutical Corporation Information
Table 122. Santen Pharmaceutical Description and Major Businesses
Table 123. Santen Pharmaceutical Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Santen Pharmaceutical Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Santen Pharmaceutical Recent Developments
Table 126. Lupin Pharmaceuticals Corporation Information
Table 127. Lupin Pharmaceuticals Description and Major Businesses
Table 128. Lupin Pharmaceuticals Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Lupin Pharmaceuticals Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Lupin Pharmaceuticals Recent Developments
Table 131. Apotex Corporation Information
Table 132. Apotex Description and Major Businesses
Table 133. Apotex Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Apotex Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Apotex Recent Developments
Table 136. Akorn Corporation Information
Table 137. Akorn Description and Major Businesses
Table 138. Akorn Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Akorn Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Akorn Recent Developments
Table 141. Fera Pharmaceuticals Corporation Information
Table 142. Fera Pharmaceuticals Description and Major Businesses
Table 143. Fera Pharmaceuticals Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Fera Pharmaceuticals Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Fera Pharmaceuticals Recent Developments
Table 146. Shenyang Xingqi Pharma Corporation Information
Table 147. Shenyang Xingqi Pharma Description and Major Businesses
Table 148. Shenyang Xingqi Pharma Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Shenyang Xingqi Pharma Ophthalmic Antivirals Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Shenyang Xingqi Pharma Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Ophthalmic Antivirals Distributors List
Table 154. Ophthalmic Antivirals Customers List
Table 155. Ophthalmic Antivirals Market Trends
Table 156. Ophthalmic Antivirals Market Drivers
Table 157. Ophthalmic Antivirals Market Challenges
Table 158. Ophthalmic Antivirals Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophthalmic Antivirals Product Picture
Figure 3. Global Ophthalmic Antivirals Market Share by Type in 2021 & 2028
Figure 3. Solutions Product Picture
Figure 4. Suspensions Product Picture
Figure 5. Gels or Ointments Product Picture
Figure 6. Global Ophthalmic Antivirals Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Others
Figure 10. Ophthalmic Antivirals Report Years Considered
Figure 11. Global Ophthalmic Antivirals Sales 2017-2028 (K Units)
Figure 12. Global Ophthalmic Antivirals Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Ophthalmic Antivirals Revenue 2017-2028 (US$ Million)
Figure 14. Global Ophthalmic Antivirals Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Ophthalmic Antivirals Sales Market Share by Region (2017-2022)
Figure 16. Global Ophthalmic Antivirals Sales Market Share by Region (2023-2028)
Figure 17. North America Ophthalmic Antivirals Sales YoY (2017-2028) & (K Units)
Figure 18. North America Ophthalmic Antivirals Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Ophthalmic Antivirals Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Ophthalmic Antivirals Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Ophthalmic Antivirals Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Ophthalmic Antivirals Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Ophthalmic Antivirals Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Ophthalmic Antivirals Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Ophthalmic Antivirals Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Ophthalmic Antivirals Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Ophthalmic Antivirals Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Ophthalmic Antivirals in the World: Market Share by Ophthalmic Antivirals Revenue in 2021
Figure 29. Global Ophthalmic Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Ophthalmic Antivirals Sales Market Share by Type (2017-2028)
Figure 31. Global Ophthalmic Antivirals Revenue Market Share by Type (2017-2028)
Figure 32. Global Ophthalmic Antivirals Sales Market Share by Application (2017-2028)
Figure 33. Global Ophthalmic Antivirals Revenue Market Share by Application (2017-2028)
Figure 34. North America Ophthalmic Antivirals Sales Market Share by Type (2017-2028)
Figure 35. North America Ophthalmic Antivirals Revenue Market Share by Type (2017-2028)
Figure 36. North America Ophthalmic Antivirals Sales Market Share by Application (2017-2028)
Figure 37. North America Ophthalmic Antivirals Revenue Market Share by Application (2017-2028)
Figure 38. North America Ophthalmic Antivirals Sales Share by Country (2017-2028)
Figure 39. North America Ophthalmic Antivirals Revenue Share by Country (2017-2028)
Figure 40. United States Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Ophthalmic Antivirals Sales Market Share by Type (2017-2028)
Figure 43. Europe Ophthalmic Antivirals Revenue Market Share by Type (2017-2028)
Figure 44. Europe Ophthalmic Antivirals Sales Market Share by Application (2017-2028)
Figure 45. Europe Ophthalmic Antivirals Revenue Market Share by Application (2017-2028)
Figure 46. Europe Ophthalmic Antivirals Sales Share by Country (2017-2028)
Figure 47. Europe Ophthalmic Antivirals Revenue Share by Country (2017-2028)
Figure 48. Germany Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 49. France Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Ophthalmic Antivirals Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Ophthalmic Antivirals Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Ophthalmic Antivirals Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Ophthalmic Antivirals Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Ophthalmic Antivirals Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Ophthalmic Antivirals Revenue Share by Region (2017-2028)
Figure 59. China Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 62. India Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Ophthalmic Antivirals Sales Market Share by Type (2017-2028)
Figure 69. Latin America Ophthalmic Antivirals Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Ophthalmic Antivirals Sales Market Share by Application (2017-2028)
Figure 71. Latin America Ophthalmic Antivirals Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Ophthalmic Antivirals Sales Share by Country (2017-2028)
Figure 73. Latin America Ophthalmic Antivirals Revenue Share by Country (2017-2028)
Figure 74. Mexico Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Ophthalmic Antivirals Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Ophthalmic Antivirals Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Ophthalmic Antivirals Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Ophthalmic Antivirals Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Ophthalmic Antivirals Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Ophthalmic Antivirals Revenue Share by Country (2017-2028)
Figure 83. Turkey Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Ophthalmic Antivirals Revenue (2017-2028) & (US$ Million)
Figure 86. Ophthalmic Antivirals Value Chain
Figure 87. Ophthalmic Antivirals Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---